A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

January 14, 2008

HIV Blocking Proteins Found in Dendritic Cells

Researchers at the University of California Los Angeles (UCLA) have found that two proteins inside dendritic cells stop the virus from “budding,” thus protecting other cells from being infected. The study appears online, ahead of publication in the journal of the Federation of American Societies for Experimental Biology.

Dendritic cells are involved in immune surveillance and protection early in the course of an infection. They’re located predominantly in the skin, mucous membranes (such as the throat or gut) and within lymph nodes. When dendritic cells encounter HIV, they use a protein called DC-SIGN to trap the virus and present it to CD4 cells to spark an immune response.

When HIV infects CD4s, the virus’s genetic material is reproduced and packaged, eventually budding from the cell and moving on to infect other cells. Even though dendritic cells can be infected with HIV, budding does not occur.

Shen Pang, PhD, an associate professor in the division of oral biology and medicine at the UCLA School of Dentistry, and Qiuwei Wang, a graduate student working with Pang, took a closer look at DC-SIGN to see if it prevents dendritic cells from producing new HIV.

Pang found that the presence of DC-SIGN, along with DC-SIGNR, a similar protein, blocked the release of HIV from dendritic cells by 95 to 99.5 percent.  Pang’s group theorizes that the proteins disrupt the ability of HIV to complete its assembly process at the outer membrane of a dentritic cell, thus preventing budding. He is encouraging other researchers to explore how this knowledge may aid efforts to produce an effective HIV vaccine.


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 3 (of 3 total)    

tsaku ali, nigeria, Abuja, Nigeria, 2008-01-17 04:44:37
More efforts should be on how to produce mass vaccine and treatment for those infected with the virus for God sake. thanx

YB4, NY, 2008-01-16 12:03:29
Lactoferrin (apart of Whey in Milk) has for a long time been shown to DC-SIGN.

Richard Foster, Lansing, 2008-01-15 11:29:21
Finally a scientist has found another pathway that can be explored for possible meds to prevent and possibly cure patients of HIV infection. This study is very promising but alas too late for those who have gone before us.

comments 1 - 3 (of 3 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    aqua_31206
    Macon
    Georgia


    Loveladyd
    Washington
    DC


    sefarady
    Los Angeles
    California


    ZanderPetros
    San Jose
    California
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.